International Journal of Hematology-Oncology and Stem Cell Research

Tehran University of Medical Sciences

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

International Journal of Hematology-Oncology and Stem Cell Research is an open-access journal published by Tehran University of Medical Sciences in Iran, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Tehran University of Medical Sciences
ISSN
2008-3009 · 2008-2207
Country
Iran
Languages
english
Access
Open access
Articles in DOAJ
747
Declared review time
12 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2020-10-22
  • PUBMED · 2014-07-01
Indexing
DOAJ · PUBMED
APC
—
Declared review time (DOAJ)
12 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

747

Most recent article

3 years ago

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

323

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

14

i10-index

27

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2023-02-24
Added to DOAJ
2020-10-22
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
IJHOSCR
Source type
journal
NLM unique ID (PubMed)
101511150
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Acute Lymphoblastic Leukemia research
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
Show all subjects (50)
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Mesenchymal stem cell research
  • Neutropenia and Cancer Infections
  • Mesenchymal stem cell research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Neutropenia and Cancer Infections
  • Platelet Disorders and Treatments
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Platelet Disorders and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
  • Chronic Myeloid Leukemia Treatments
  • MicroRNA in disease regulation
  • Childhood Cancer Survivors' Quality of Life
  • MicroRNA in disease regulation
  • Childhood Cancer Survivors' Quality of Life
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Hematological disorders and diagnostics
  • Hematological disorders and diagnostics
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Neuroblastoma Research and Treatments
  • Cancer survivorship and care
  • Neuroblastoma Research and Treatments
  • Cancer survivorship and care

Keywords (DOAJ)

  • stem cell research
  • hematology
  • oncology
  • stem cell transplantion

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: